Gene Information
Gene Name
|
BCHE |
Gene ID
|
590
|
Gene Full Name
|
butyrylcholinesterase |
Gene Alias
|
E1; CHE1; CHE2; BCHED |
Transcripts
|
ENSG00000114200
|
Virus
|
HBV |
Gene Type
|
protein coding |
HPA Location Info
|
|
HPA Protein Class Info
|
Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins |
Uniport_ID
|
P06276
|
HGNC ID
|
HGNC:983
|
VEGA ID
|
OTTHUMG00000158131
|
OMIM ID
|
177400 |
String ID
|
9606.ENSP00000264381
|
Drugbank ID
|
BE0002180
|
PharmGKB ID
|
PA25294
|
FDA Approved Drug
|
Mivacurium;Succinylcholine |
Target gene [BCHE] related to VISs
DVID |
Chromosome |
HM |
TFBS |
CA |
Sum of Overlapped Records |
Detail |
1013991 |
chr3 |
2 |
2 |
|
4 |
View |
Relationship between gene expression and immune infiltrating cell level
Data ID |
Disease |
Sample number |
Sample type |
LIHC (TCGA) |
Liver hepatocellular carcinoma |
424 |
Liver hepatocellular carcinoma HCV (HBV+)(86), Liver hepatocellular carcinoma HCV (HBV-)(19), Liver hepatocellular carcinoma (HBV+)(209), Liver hepatocellular carcinoma (HBV+)(60), Paracancerous HCV (HBV+)(4), Paracancerous (HBV-)(28), Paracancerous (HBV+)(18) |
> Dataset: LIHC
|
HeatMap of cell type fractions in all samples
|
Lollipop of BCHE expression and immune infiltrating cell level correlation result in HBV+ samples
|
BCHE expression: Low -> High
|
|
|
|
|